Point of Care Technology Market Size

ID: MRFR/MED/0658-HCR

100 Pages

Rahul Gotadki

October 2025

Point of Care Technology Market Research Report By Product Type (Blood Glucose Monitoring Devices, Diagnostic Imaging Devices, Cardiac Monitoring Devices, Infectious Disease Testing Devices), By End User (Hospitals, Clinics, Home Care Settings, Ambulatory Surgical Centers), By Technology (Microfluidics, Lateral Flow Technology, Biosensors, Molecular Diagnostics), By Application (Diabetes Management, Infectious Diseases, Cardiology, Oncology) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Fore... read more

Point of Care Technology Market Infographic

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Point Of Care Technology Size

Point of Care Technology Market Growth Projections and Opportunities

The Point of Care Technology market is growing rapidly due to several variables affecting modern healthcare. Demand for instant diagnostic outcomes is a major factor. Patients and healthcare professionals want speedier testing and diagnostic solutions to speed up decision-making and improve healthcare treatments.

The rising emphasis on early illness diagnosis drives market growth. Rapid diagnosis, early intervention, and better patient outcomes depend on point-of-care technology. Quick diagnostic tests at the point of care are vital to the individual's health and may reduce advanced illness treatment expenses, which benefits public health.

The growing role of point-of-care technology in distant and underserved locations drives market expansion. These technologies help provide healthcare in areas without centralized facilities. Point of care technologies enable remote healthcare access by allowing doctors to diagnose outside of labs.

Portable gadget technology is changing the market. This increased awareness of point-of-care technology in pandemic planning and response has hastened their implementation.

Healthcare's patient-centric focus also drives industry growth. Point-of-care diagnostics satisfy patients' desire for speed and convenience. Diagnostics at the point of treatment improve the patient experience and enable patients to actively engage in their healthcare, especially with the rise of customized medicine.

Point-of-care technologies are being used in home healthcare. This extension into home healthcare allows people to monitor chronic diseases, diagnose themselves, and better interact with doctors. The market's expansion goes beyond traditional healthcare institutions to patient self-care.

Cost-efficiency and time savings drive point-of-care technology adoption. These technologies reduce the need for centralized labs and streamline diagnostics, saving money. Fast test results save time and money on healthcare resources and logistics.

The seamless integration of point-of-care technology with EHR improves treatment continuity. This interface lets healthcare practitioners see real-time patient data, make educated decisions, and streamline workflow. Point-of-care and EHR systems work together to provide more complete and linked healthcare.

Biomarker detection has improved point-of-care diagnostics. Modern technology can identify more biomarkers, enabling more accurate and complete diagnostic testing at the point of service. Continuous innovation keeps point-of-care technology at the forefront of diagnostics.

The market also benefits from regulatory authorities supporting speedy and decentralized testing. Point-of-care technologies have developed and been used thanks to regulatory permissions. Regulatory authorities' support gives these technologies legitimacy and boosts healthcare ecosystem adoption.

Global health efforts and partnerships to improve healthcare access and outcomes have also boosted the point of care technology industry. Collaboration to reduce healthcare inequities and improve diagnostics drives market dynamics.

Point of Care Technology Market Size Graph

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the expected market size of the Point of Care Technology Market by 2035?

The Point of Care Technology Market is expected to be valued at 74.7 USD Billion by 2035.

What is the estimated compound annual growth rate (CAGR) for the Point of Care Technology Market from 2025 to 2035?

The estimated CAGR for the Point of Care Technology Market from 2025 to 2035 is 7.29%.

Which region is projected to have the highest market value in the Point of Care Technology Market by 2032?

North America is projected to have the highest market value at 24.2 USD Billion by 2032.

What is the market size of Blood Glucose Monitoring Devices in 2032?

The market size for Blood Glucose Monitoring Devices is expected to reach 15.0 USD Billion by 2032.

Who are the major players in the Point of Care Technology Market?

Major players in the market include Siemens Healthineers, Becton Dickinson and Company, and Abbott Point of Care, among others.

What is the expected market size for Diagnostic Imaging Devices by 2032?

The expected market size for Diagnostic Imaging Devices is projected to be 18.0 USD Billion by 2032.

What is the projected market size for Cardiac Monitoring Devices in 2032?

The projected market size for Cardiac Monitoring Devices is expected to be 12.0 USD Billion by 2032.

What are the growth drivers for the Point of Care Technology Market?

Key growth drivers include advancements in technology and the increasing prevalence of chronic diseases.

What is the estimated market value for Infectious Disease Testing Devices by 2032?

The estimated market value for Infectious Disease Testing Devices is expected to be 15.5 USD Billion by 2032.

Which region is expected to have the smallest market size in 2032 for the Point of Care Technology Market?

The Middle East and Africa (MEA) region is expected to have the smallest market size at 0.2 USD Billion by 2032.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per Market Research Future Analysis, the Point of Care Technology Market was valued at 34.5 USD Billion in 2024 and is projected to reach 74.7 USD Billion by 2035, growing at a CAGR of 7.29% from 2025 to 2035. The market is driven by the increasing demand for rapid diagnostic solutions, technological advancements, and the rise in home healthcare services.

Key Market Trends & Highlights

The Point of Care Technology Market is witnessing significant growth due to various trends.

The market is expected to grow from 34.5 USD Billion in 2024 to 74.7 USD Billion by 2035. Blood Glucose Monitoring Devices are projected to increase from 8.0 USD Billion in 2023 to 15.0 USD Billion by 2032. Diagnostic Imaging Devices are anticipated to grow from 10.0 USD Billion in 2023 to 18.0 USD Billion by 2032. The North America region is expected to dominate the market, growing from 12.5 USD Billion in 2023 to 24.2 USD Billion by 2032.

Point of Care Technology Market

CAGR

7.29%

Market Size & Forecast

2022 Market Size	USD 29.9 Billion
2024 Market Size	USD 34.5 Billion
2035 Market Size	USD 74.7 Billion
CAGR (2025-2035)	7.29%
Largest Regional Market Share in 2023	North America.

Major Players

Siemens Healthineers, Becton Dickinson and Company, Abbott Point of Care, Roche Diagnostics, Thermo Fisher Scientific, AccuTec Blades, bioMérieux, Quidel Corporation, Danaher Corporation, Abbott Laboratories, Diagnostics For All, Ortho Clinical Diagnostics, MeMed, Hologic, Cepheid.

Market Trends

The growth of the global point-of-care technology market is fundamentally driven by the need for fast-paced diagnostic testing and the growth of the home healthcare market. The expansion of chronic diseases and the push for more decentralized care systems are accelerating the market for these technologies. There is a growing demand from Healthcare providers for solutions that would allow timely decision-making, better patient outcomes and enable more efficient processes. Mobile Health applications and diagnostic devices are examples of advanced technological innovations that are making the provision of health services easier.

This is a space that has a lot of potential to thrive.

As telemedicine grows, incorporating point-of-care technologies within telehealth will enhance the overall patient experience. Moreover, increasing legal endorsement for novel diagnostic means is expected to encourage investments in R&D and subsequent product releases. Manufacturers can shift their attention to designing portable devices to accommodate various settings instead of focusing on clinics and hospitals, thus easing the use of point-of-care testing for professionals and clients. Recently, however, there has been strong evidence of increasing focus on digital health systems, in which point-of-care technologies are embedded within devices that can be worn on the body.

Further development worth mentioning is the inclusion of artificial intelligence and machine learning, especially in diagnostics, as it facilitates a more accurate and fast patient data analysis. Moreover, cooperative activities between healthcare institutions and providers, technology developers and research centers are improving the creation and implementation of point-of-care technologies. This collaborative model embodies the provision of effective responses to the changing dynamics of the healthcare system and thus improves the efficiency of the healthcare system.

Point of Care Technology Market Market Drivers

Market Growth Projections

The Global Point of Care Technology Market Industry is poised for substantial growth, with projections indicating a market value of 34.5 USD Billion in 2024 and an anticipated increase to 74.7 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate of 7.29% from 2025 to 2035, underscoring the increasing adoption of point of care technologies across various healthcare settings. The market dynamics are influenced by factors such as technological advancements, rising chronic disease prevalence, and the shift towards home healthcare solutions. These projections suggest a robust future for the industry, driven by ongoing innovations and evolving healthcare needs.

Rising Demand for Rapid Diagnostics

The Global Point of Care Technology Market Industry experiences a notable surge in demand for rapid diagnostic solutions. This trend is driven by the need for timely and accurate patient assessments, particularly in emergency and primary care settings. The ability to deliver results within minutes rather than days enhances clinical decision-making and patient outcomes. For instance, point of care testing for infectious diseases and chronic conditions is becoming increasingly prevalent. As a result, the market is projected to reach 34.5 USD Billion in 2024, reflecting a growing recognition of the importance of immediate diagnostic capabilities.

Shift Towards Home Healthcare Solutions

The Global Point of Care Technology Market Industry is witnessing a paradigm shift towards home healthcare solutions. This transition is fueled by the increasing preference for at-home care, driven by factors such as convenience, cost-effectiveness, and patient comfort. Point of care technologies enable patients to receive quality care in their homes, reducing the need for hospital visits. Devices such as home testing kits and telehealth platforms are becoming increasingly popular. This trend not only enhances patient satisfaction but also alleviates the burden on healthcare facilities, suggesting a promising future for point of care technologies in home healthcare settings.

Increasing Prevalence of Chronic Diseases

The Global Point of Care Technology Market Industry is significantly influenced by the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory conditions. As these diseases require continuous monitoring and management, point of care technologies offer a viable solution for patients and healthcare providers. For instance, glucose monitoring devices and portable ECG machines enable real-time tracking of patient health. This growing demand for chronic disease management tools is likely to propel the market towards an estimated value of 74.7 USD Billion by 2035, highlighting the critical role of point of care solutions in modern healthcare.

Regulatory Support and Reimbursement Policies

Regulatory support and favorable reimbursement policies are crucial drivers of the Global Point of Care Technology Market Industry. Governments and health organizations are increasingly recognizing the value of point of care testing in improving healthcare delivery. Initiatives aimed at streamlining the approval process for new devices and expanding reimbursement coverage for point of care services encourage innovation and adoption. For example, policies that support the integration of point of care testing into routine clinical practice are likely to enhance market growth. This supportive regulatory environment fosters a landscape conducive to the advancement of point of care technologies.

Technological Advancements in Medical Devices

Technological innovations play a pivotal role in shaping the Global Point of Care Technology Market Industry. The integration of advanced technologies such as artificial intelligence, machine learning, and miniaturized devices enhances the functionality and accuracy of point of care testing. These advancements facilitate the development of portable devices that can be used in various settings, including remote areas. For example, handheld ultrasound devices and portable blood analyzers are gaining traction. This technological evolution is expected to contribute to a compound annual growth rate of 7.29% from 2025 to 2035, indicating a robust future for the industry.

Market Segment Insights

Point of Care Technology Market Product Type Insights

In 2023, the Point of Care Technology Market is valued at approximately 32.08 USD Billion, a landscape supported by various innovative Product Types that cater to specific medical needs. The market can be segmented into key areas such as Blood Glucose Monitoring Devices, Diagnostic Imaging Devices, Cardiac Monitoring Devices, and Infectious Disease Testing Devices.

Notably, Blood Glucose Monitoring Devices emerge as a significant segment, valued at around 8.0 USD Billion in 2023; by 2032, this valuation is projected to increase to 15.0 USD Billion.This growth illustrates the increasing prevalence of diabetes and the essential need for continuous glucose monitoring, highlighting a clear demand for these devices in both clinical and consumer settings. Following closely, Diagnostic Imaging Devices are valued at 10.0 USD Billion in 2023, with projections reaching 18.0 USD Billion by 2032, emphasizing their importance for instant diagnostics that aid in faster treatment decisions and improved patient outcomes.

The demand for rapid and accurate diagnostics reinforces the significance of this category in the Point of Care Technology Market.Cardiac Monitoring Devices represent another crucial segment, valued at 7.0 USD Billion in 2023 and growing to a noteworthy 12.0 USD Billion by 2032, reflecting the increasing incidence of cardiovascular conditions and the need for continuous monitoring solutions to enhance patient safety.

Point of Care Technology Market End User Insights

The Point of Care Technology Market is increasingly segmented by End User, revealing diverse applications and growth potential in various settings. As of 2023, the market is valued at 32.08 billion USD, showcasing significant adoption of point-of-care technologies across facilities. Hospitals have emerged as a prominent setting, primarily due to their need for rapid diagnostic tools and patient management systems. Clinics are experiencing growth as they integrate point-of-care testing to enhance patient throughput and improve healthcare outcomes.Home care settings are also gaining traction as patients prefer receiving care in familiar environments, facilitating efficient monitoring and reducing hospital visits.

Ambulatory surgical centers dominate the market for quick, minimally invasive procedures and require streamlined technologies for efficient patient turnover. Trends such as the rise in chronic diseases and the demand for personalized healthcare are driving the Point of Care Technology Market revenue upwards, supported by innovative product developments. However, challenges like regulatory requirements and the need for skilled personnel in these settings persist.The Point of Care Technology Market industry presents numerous opportunities, particularly in expanding access to care through mobile health applications and remote monitoring solutions, ensuring better health outcomes within the evolving healthcare landscape.

Point of Care Technology Market Technology Insights

The Point of Care Technology Market is poised for significant expansion, with a projected valuation reaching 32.08 billion USD in 2023 and expected to grow to 60.5 billion USD by 2032. The market growth is driven by the increasing demand for rapid diagnostic solutions that ensure timely patient care. The segmentation of this market includes various technologies, notably Microfluidics, Lateral Flow Technology, Biosensors, and Molecular Diagnostics, each contributing uniquely to its advancement.

Microfluidics is particularly crucial due to its ability to perform multiple analyses with minimal sample volumes, enhancing testing efficiency. Lateral Flow Technology, widely utilized in home testing kits, significantly contributes to the market by providing simple and quick results, thereby improving access to diagnostics. Biosensors are also notable, as they integrate biological sensing elements to deliver real-time results in clinical and home environments. Molecular Diagnostics plays a vital role due to its precision in detecting genetic disorders and infectious diseases, marking a trend toward personalized medicine.

Overall, the Point of Care Technology Market statistics underscore a robust growth trajectory, influenced by these pivotal technologies driving innovation and improving healthcare outcomes.

Point of Care Technology Market Application Insights

The Point of Care Technology Market is witnessing robust growth, with a valuation of 34.5 USD Billion in 2024, projected to reach 74.7 USD Billion by 2035. Within the Application segment, various areas such as Diabetes Management, Infectious Diseases, Cardiology, and Oncology play pivotal roles. Diabetes Management is particularly critical as it addresses the increasing prevalence of diabetes globally, driving demand for advanced monitoring solutions. The Infectious Diseases sector also remains significant, especially in light of recent global health challenges that have highlighted the need for rapid diagnostic capabilities.

Cardiology benefits from technological advances that enable timely detection and treatment of heart-related issues, a major health concern worldwide. On the other hand, Oncology is growing as a result of innovations that enhance early cancer detection and patient management. Overall, the Point of Care Technology Market segmentation reflects the industry's response to urgent healthcare needs, bolstering market growth through enhanced accessibility and efficiency in patient care. The evolving technologies in these applications are essential in improving health outcomes and reducing healthcare costs, thereby driving the Point of Care Technology Market revenue.

Get more detailed insights about Point of Care Technology Market Research Report - forecast till 2035

Regional Insights

The Point of Care Technology Market has shown substantial growth across various regions, with North America leading with a valuation of 12.5 USD Billion in 2023, expected to grow to 24.2 USD Billion by 2032, indicating its majority holding in the market. This dominance can be attributed to advanced healthcare infrastructure and high adoption of innovative technologies. Following closely, Europe is valued at 8.5 USD Billion in 2023 and is projected to reach 16.8 USD Billion in 2032, highlighting its significant penetration in the healthcare industry.

The APAC region, valued at 7.5 USD Billion in 2023 and expected to grow to 14.3 USD Billion by 2032, is gaining traction due to increasing investments in healthcare technology and a growing patient population. In contrast, South America and MEA represent smaller yet notable portions of the market, with South America starting at 2.5 USD Billion in 2023 and moving to 5.0 USD Billion by 2032, while MEA reflects a value of 1.1 USD Billion in 2023.

The challenges and opportunities in these regions are shaped by economic conditions, regulatory frameworks, and the need for improved healthcare delivery, contributing to the overall landscape of the Point of Care Technology Market revenue and its segmentation.

Point of Care Technology Market Regional Insights

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Key Players and Competitive Insights

The Point of Care Technology Market is characterized by a dynamic competitive landscape driven by the increasing demand for rapid diagnostic solutions that facilitate immediate patient care. This market encompasses a wide array of devices and technologies designed for use at the point of care, bridging the gap between hospital laboratories and patient treatment. Companies operating in this space are focused on innovation, quality, and compliance with regulatory standards, leading to a variety of product offerings that cater to diverse health needs across different settings.

As the healthcare sector continues to evolve with advancements in technology, the competition in the point-of-care technology market intensifies, with firms striving to enhance their product portfolios and expand their market reach.Siemens Healthineers stands out in the Point of Care Technology Market due to its robust portfolio of diagnostic tools and solutions tailored for use in various medical environments. With a strong emphasis on accuracy and efficiency, Siemens Healthineers has developed cutting-edge point-of-care diagnostics that streamline testing processes and improve patient outcomes.

The company leverages its extensive research and development capabilities to constantly innovate and upgrade its technology, ensuring it meets the ever-changing demands of healthcare providers and patients alike. Its well-established brand reputation and a global network of distribution channels further strengthen its position in the market, enabling Siemens Healthineers to maintain a competitive edge through quality offerings and superior customer service.Becton Dickinson and Company is also a pivotal player in the Point of Care Technology Market, recognized for its commitment to advancing patient care through innovative medical technologies.

The company focuses on developing point of care products that enhance the accuracy and speed of diagnostics, thereby facilitating timely clinical decision-making. Becton Dickinson has leveraged its strong expertise in medical devices to create solutions that cater to a wide array of clinical needs, from blood testing to infectious disease diagnostics. By fostering partnerships and collaborations within the healthcare ecosystem, the company enhances its market presence and ensures that it is at the forefront of technological advancements, aligning its goals with the needs of healthcare facilities and practitioners.

Becton Dickinson's reliance on high-quality standards and regulatory compliance further solidifies its reputation in the market as a trusted provider of point-of-care technologies.

Key Companies in the Point of Care Technology Market market include

Industry Developments

The Point of Care Technology Market is experiencing significant developments, particularly as companies like Siemens Healthineers and Abbott Point of Care continue to innovate with rapid diagnostic solutions. Becton Dickinson and Company has made strides in enhancing their product offerings, while Roche Diagnostics and Thermo Fisher Scientific are focusing on precision medicine and disease management, driving growth in the sector. AccuTec Blades and bioMérieux are equally contributing with advancements in test accuracy and efficiency. Current affairs indicate a heightened demand for at-home testing solutions in light of ongoing health challenges.

In terms of merger and acquisition activity, Quidel Corporation has gained traction with strategic partnerships aimed at expanding its diagnostic capabilities. Furthermore, Danaher Corporation's recent moves have positioned them for growth through enhanced technology integration and service offerings. Abbott Laboratories continues to lead with new product launches that respond to market needs, while Diagnostics For All and Ortho Clinical Diagnostics are addressing accessibility in diagnostics. The overall market is seeing an upward trend in valuation as demand for quick and effective testing solutions intensifies, impacting companies’ growth trajectories positively.

Future Outlook

Point of Care Technology Market Future Outlook

The Global Point of Care Technology Market is projected to grow at a 7.29% CAGR from 2025 to 2035, driven by technological advancements, increasing demand for rapid diagnostics, and a shift towards decentralized healthcare.

New opportunities lie in:

Develop AI-driven diagnostic tools for personalized patient care. Expand telehealth integration with point of care devices. Invest in portable testing solutions for remote healthcare settings.

By 2035, the market is expected to achieve substantial growth, reflecting a robust demand for innovative point of care solutions.

Market Segmentation

Point of Care Technology Market End User Outlook

Hospitals
Clinics
Home Care Settings
Ambulatory Surgical Centers

Point of Care Technology Market Technology Outlook

Microfluidics
Lateral Flow Technology
Biosensors
Molecular Diagnostics

Point of Care Technology Market Application Outlook

Diabetes Management
Infectious Diseases
Cardiology
Oncology

Point of Care Technology Market Product Type Outlook

Blood Glucose Monitoring Devices
Diagnostic Imaging Devices
Cardiac Monitoring Devices
Infectious Disease Testing Devices

Report Scope

Attribute/Metric	Details
Market Size 2023	32.08 (USD Billion)
Market Size 2024	34.5 (USD Billion)
Market Size 2035	74.7 (USD Billion)
Compound Annual Growth Rate (CAGR)	7.29% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2018-2023
Market Forecast Units	USD Billion
Key Companies Profiled	Siemens Healthineers, Becton Dickinson and Company, Abbott Point of Care, Roche Diagnostics, Thermo Fisher Scientific, AccuTec Blades, bioMérieux, Quidel Corporation, Danaher Corporation, Abbott Laboratories, Diagnostics For All, Ortho Clinical Diagnostics, MeMed, Hologic, Cepheid
Segments Covered	Product Type, End User, Technology, Application, Regional
Key Market Opportunities	Telehealth integration expansion, Rising chronic disease prevalence, Increasing demand for rapid diagnostics, Advancements in portable devices, Growth in home healthcare solutions
Key Market Dynamics	Increasing prevalence of chronic diseases, Demand for rapid diagnostics, Advancements in mobile health technologies, Rising geriatric population, Focus on decentralized healthcare delivery
Countries Covered	North America, Europe, APAC, South America, MEA